Anticonvulsant treatments of dysphoric mania: A trial of gabapentrin, lamotrigine and carbamazepine in Iran

Neuropsychiatric Disease and Treatment

Volumn 4, Issue 1 B, 2008, Pages 227-234

  Mokhber, Naghmeh ^a   Lane, Carol J ^b   Azarpazhooh, Mohamad R ^a   Salari, Elham ^a   Fayazi, Reza ^a   Shakeri, Mohamad T ^a   Young, Allan H ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anticonvulsant; Depression; Dysphoric mania; Manic depression; Mood stabilizer

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPHORIC MANIA; EVENING DOSAGE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MANIA; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MONOTHERAPY; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN PRURITUS; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYMPTOMATOLOGY; TREATMENT DURATION; VERTIGO;

EID: 41549121012     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Altshuler LL, Keck PE, McElroy SL, et al. 1999. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord, 1:61-5.
2. Akiskal HS. 2005. Mood Disorders: Clinical Features. In: Sadock BJ, Sadock VA eds. Comprehensive Text Book of Psychiatry. 8th ed. Philadelphia: Lippincott Williams and Wilkins, p 1636.
3. Akiskal HS, Hantouche EG, Bourgeois ML, et al. 1998. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord, 50(2-3):175-86.
4. Baker RW, Tohen M, Fawcett J, et al. 2003. Acute dysphoric mania: treatment response to olanzapine versus placebo. J Clin Psychopharmacol, 23:132-7.
5. Berk M 1999. Lamotrigine and the treatment of mania in bipolar disorder. Eur Neuropsychopharmacol, 9(Suppl 4):S119-23.
6. Bowden CL, Calabrese JR, Sachs G, et al. 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry, 60:392-400.
7. Bowden CL. 2002. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother, 3:1513-19.
8. Bowden CL, Calabrese JR, McElroy SL, et al. 1999. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry, 45:953-8.
9. Bowden CL, Mitchell P, Suppes T. 1999. Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol, 9(Suppl 4): S113-17.
10. Bowden CL. 1998. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology, 19:194-9.
11. Bowden CL. 1995. Predictors of response to divalproex and lithium. J Clin Psychiatry, 56(Suppl 3):25-30.
12. Butcher JN. 2004. Personality assessment without borders: adaptation of the MMPI-2 across cultures. J Pers Assess, 83:90-104.
13. Calabrese JR, Shelton MD, Rapport DJ, et al. 2002. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry, 65(Suppl 3):5-9.
14. Calabrese JR, Bowden CL, McElroy SL, et al. 1999. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry, 156:1019-23.
15. Calabrese JR, Bowden CL, Sachs GS, et al. 1999. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry, 60:79-88.
16. Calabrese JR, Rapport DJ, Shelton MD, et al. 1998. Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology, 38:185-91.
17. Carta MG, Hardoy MC, Hardoy MJ, et al. 2003. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Disord, 75:83-91.
18. Cassidy F, Murry E, Forest K, et al. 1998. Signs and symptoms of mania in pure and mixed episodes. J Affect Disord, 50(2-3):187-201.
19. Clothier J, Swann AC, Freeman T. 1992. Dysphoric mania. J Clin Psychopharmacol, 12(Suppl 1):13S-16S.
20. Dilsaver SC, Chen YR, Shoaib AM, et al. 1999. Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations. Am J Psychiatry, 56:426-30.
21. Dilsaver SC, Swann AC, Shoaib AM, et al. 1993. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. J Psychiatry Neurosci, 18:61-6.
22. Duckworth JC, Anderson WP. 1995. MMPI and MMPI-2 Interpretation Manual for Counselors and Clinicians. Bristol, Pa, Accelerated Development.
23. Erfurth A, Kammerer C, Grunze H, et al. 1998. An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res, 32:261-4.
24. Ghaemi SN, Gaughan S. 2005. Novel anticonvulsants: a new generation of mood stabilizers? Harv Rev Psychiatry, 8:1-7.
25. Ghaemi SN, Katzow JJ, Desai SP, et al. 1998. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry, 59:426-9.
26. Grunze H, Erfurth A, Amann B, et al. 1999. Gabapentin in the treatment of mania. Fortschr Neurol Psychiatr, 67:256-60.
27. Ichim L, Berk M, Brook S. 2000. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry, 12:5-10.
28. Kraepelin E. 1921. Manic-depressive insanity and paranoia. Edinburgh. E and S Livingstone.
29. Kruger S, Trevor Young L, Braunig P. 2005. Pharmacotherapy of bipolar mixed states. Bipolar Disord, 7:205-15.
30. Leweke FM, Bauer J, Elger CE. 1999. Manic episode due to gabapentin treatment. Br J Psychiatry, 175:291a.
31. Macdonald KJ, Young LT. 2002. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy. CNS Drugs, 16:549-62.
32. Maidment ID. 2001. Gabapentin treatment for bipolar disorders. Ann Pharmacother, 35:1264-9.
33. Margolese HC, Beauclair L, Szkrumelak N, et al. 2003. Hypomania induced by adjunctive lamotrigine. Am J Psychiatry, 160:183-4.
34. Marken PA, Pies RW. 2006. Emerging treatments for bipolar disorder: safety and adverse effect profiles. Ann Pharmacother, 40:279-85.
35. McElroy SL, Keck PE, Pope HG, et al. 1992. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry, 149:1633-44.
36. Mootabi F. 1995. Preparation and normalization of MMPI-2 questionnaire in Tehran city. Unpublished, personal communication.
37. Muzina DJ, Elhaj O, Gajwani P, et al. 2005. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl, 426:21-8.
38. Pande AC, Crockatt JG, Janney CA, et al. 2000. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord, 2(3 pt 2):249-55.
39. Perugi G, Toni C, Ruffolo G, et al. 1999. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Pharmacopsychiatry, 32:136-41.
40. Post RM, Ketter TA, Denicoff K, et al. 1996. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl), 128:115-29.
41. Sethi MA, Mehta R, Devanand DP. 2003. Gabapentin in geriatric mania. J Geriatr Psychiatry Neurol, 16:117-20.
42. Short C, Cooke L. 1995. Hypomania induced by gabapentin. Br J Psychiatry, 166:679-80.
43. Sokolski KN, Green C, Maris DE, et al. 1999. Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology. Ann Clin Psychiatry, 11:217-22.
44. Soutullo CA, Casto LS, Keck PE. 1998. Gabapentin in the treatment of adolescent mania: a case report. J Child Adolesc Psychopharmacol, 8:81-5.
45. Swann AC, Secunda SK, Katz MM, et al. 1993. Specificity of mixed affective states: clinical comparison of dysphoric mania and agitated depression. J Affect Disord, 28:81-7.
46. Tohen M, Jacobs TG, Grandy SL, et al. 2000. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry, 57:841-9.
47. Tohen M, Sanger TM, McElroy SL, et al. 1999. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry, 156:702-9.
48. Yatham LN, Kusumakar V, Calabrese JR, et al. 2002. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry, 63:275-83.
49. Young LT, Robb JC, Hasey GM, et al. 1999. Gabapentin as an adjunctive treatment in bipolar disorder. J Affect Disord, 55:73-7.
50. Vieta E, Martinez-Aran A, Nieto E, et al. 2000. Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry, 15:433-7.
51. Wang PW, Santosa C, Schumacher M, et al. 2002. Gabapentin augmentation therapy in bipolar depression. Bipolar Disord, 4:296-301.